First moon rocks on Earth in half a century arrive in UK
The first samples of moon dust brought back to Earth for more than 50 years are in the UK - being studied by scientists in Milton Keynes.
"It really humbles me to think that I am one of the seven billion plus people on this planet who has a chance to work with these precious samples," said Professor Mahesh Anand.
The professor of planetary science and exploration at The Open University is just one of seven international scientists chosen by China to study the samples, and travelled to Beijing to pick them up.
They are the first moon rocks brought to Earth since the last Soviet Luna mission of 1976.
Knowing how rare the samples are, Prof Anand was reluctant to let them out of his sight on his journey back from China - so he carried them in his hand luggage.
"I couldn't risk losing them," he told Sky News, speaking from a train to Manchester where he was still carrying the samples to show graduating students.
"Today, when I'm carrying one of these samples with me, they are actually in triple-sealed containers. Of course, these are not coming into contact with any terrestrial atmosphere."
Prof Anand has spent his career studying moon samples brought back to Earth by the Apollo missions.
Those samples were collected from the six moon landing sites where astronauts walked.
0:44
These new samples, collected by China's Chang'e 5 mission in 2020, come from a completely different part of the moon.
"It turns out that from a chemical point of view, they are very, very different and they are telling us something very different about the moon's geological history," Prof Anand said.
3:07
He and his team hope to better understand the origins of the moon and the history of elements that are essential for life on Earth, like hydrogen, carbon and nitrogen.
That work is "absolutely crucial" for plans to get humans living on the moon, he said.
He added: "I have a huge obligation and huge responsibility, but I'm just so happy to be given a chance.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Independent
33 minutes ago
- The Independent
First cases of Covid variant NB.1.8.1 detected in England as virus spreads across UK
The first cases of a new Covid-19 variant have been detected in England as the virus spreads across Britain, the UK 's health agency has confirmed The UK Health Security Agency (UKHSA) said 13 cases of Covid strain NB.1.8.1 had been recorded in England, with 'small numbers' detected across the UK. It's unclear how many cases of the new strain, which now account for just over 10 per cent of global infections, have been recorded in Scotland, Wales or Northern Ireland. Since first being recognised in January 2025, the omicron variant has spread to several states across the US, Australia, Thailand and is the most dominant variant in China and Hong Kong. UKHSA deputy director Dr Gayatri Amirthalingam said it was unlikely to pose more severe disease than other variants. Common symptoms align with typical Omicron subvariants and include fatigue, fever, muscle aches and a sore throat, according to the World Health Organisation. But given the dwindling number of people testing for Covid-19, it has become increasingly difficult to know the true number of infections. The World Health Organisation has designated the NB.1.8.1 as a 'variant under monitoring', and comprises around 10.7 per cent of all submitted sequences worldwide. While it first appeared in samples at the beginning of this year, data from GISAID, a global data of genetic sequences of major disease-causing viruses, show that the first known cases were registered at the end of April. Current Covid jabs are expected to remain effective against this variant and protect anyone infected from severe illness. Dr Gayatri Amirthalingam, UKHSA deputy director, told The Independent: 'It is normal for viruses to mutate and change over time. UKHSA is monitoring all available data relating to SARS-CoV-2 variants in the UK and abroad, and we continue to publish our findings in our regular Flu and COVID-19 surveillance reports. 'NB.1.8.1 has been detected in small numbers in the UK to date, but international data suggests that it is growing as a proportion of all COVID-19 cases. 'Based on the available information so far however, there is no evidence to suggest that this variant causes more severe disease than previous variants, or that the vaccines in current use will be less effective against it.'
BBC News
an hour ago
- BBC News
How weight loss injections dey affect pregnancy and contraceptives?
Di UK medicines regulator don warn women wey dey use weight loss injections say make dem find beta contraception use. Di Medicines and Healthcare products Regulatory Agency (MHRA) say e neva clear weda medicine like Wefgovy and Mounjaro fit affect belle. E also warn say dis injections wey you dey see so fit make di contraceptives to no work as e dey work for pipo wey dey overweight or obese. Fear dey say wit di way wey dis 'skinny jabs' dem dey trend, plenti women no dey use drugs safely or even get beta advice as to how dem go use am. Di thinking be say di side effects of dis medication wey be vomiting and diarrhoea and di fact say dem dey slow down di way belle dey take empty mean say di contraceptive medicine fit no enta bodi well. Di MHRA say women suppose use contraceptive togeda wit GLP-1 medicines and for a certain period afterwards before dem try to get belle - two months for Wegovy and Ozempic, and one month for Mounjaro. Dem also advice say pesin wey dey use Mounjaro and oral contraceptives get two options. Either dem go follow di contraception wit condoms for four weeks afta dem start di injection or else make dem change contraception go coil or implant. Advice for di use of contraception alreadi dey di leaflet wey dey follow di medicine but MHRA don issue dia own guidance join. Di drugs safety board say make pesin no take di weight-loss injections if: Dem suppose dey give women dis informate wen dem start to dey collect di injections, but worry dey say di warning no dey enta well. Natasha Major, 26, start to use Mounjaro to lose weight bifor she plan to born her third pikin in a few years. But e shock am as just six weeks later, she find out say, she don carry belle. She bin dey take contraceptive pill dat time. She tok say, "I get polycystic ovaries too, so I no dey quick-quick get belle like dat. So e even shock me pass say e easy to carry belle like dat, bicos e no make sense to me." She den start to dey worry about weda she go harm her pikin or weda di baby no go grow well. Natasha come follow her doctor tok for advice and na so dem tell am, make she stop di medicine. She say, "we don pass di first shock nand now dey very happy. Di last time wey I take di injection na just three hours bifor I find out say I don carry belle and I neva take am since dat time." Natasha add say, "I bin do early scan to make sure say di belle make sense and e dey okay, baby bin get small heartbeat and evritin dey good". Di MHRA and doctors and pharmacists dey worry say dem no dey use di popular GLP-1 medicine like Wegovy, Mounjaro, Saxenda, Victoza and Ozempic, safely. Dis prescription medicines dey licensed to treat obesity (and type 2 diabetes for Ozempic). E dey make pipo to feel full by acting as di hormone wey bodi dey release afta pesin don chop. Mounjaro dey also work wit anoda hormone wey dey linked to appetite and blood sugar control. Normally, na pipo wey get very high BMI, na im NHS dey give di drugs but pipo fit buy am for chemists. E don popular sotay dem don dey sell am illegally for social media and for beauty saons witout medical advice as sharp-sharp way to lose weight. Di MHRA dey advise pipo make dem follow di prescriber tok about di risks and benefits of taking dem, and understand di potential side-effects by talking to a doctor or pharmacist. E don act now because e don receive around 40 reports relating to pregnancy wey dem make to im Yellow Card scheme, wia di public fit report suspected side-effects of medicines. Some of dis be pregnancies wey hapun by mistake. Di chief safety officer for di MHRA, Dr Allison Cave tok say dem find evidence for animal studies say, "dis medicine dem fit harm unborn pikin. But we no know weda e go get di same effect for human beings, we need more data for dat one". Dem no use women wey dey child bearing age do dis clinical trial and na why safety information no dey for dem. Dr Cave say if pesin get belle and dem dey take di medicine, make dem follow dia doctor tok on how to stop am as soon as possible. Di vice chairwoman for di National Pharmacy Association, Sukhi Basra tok say make women go pharmacist for advice if dem dey confused as to wen dem suppose to stop to dey take di drugs. Dr Bassel Wattar wey be sabi pesin on pregnancy and consultant for Epsom and St Helier University Hospitals, say di implant or intrauterine coil na "more ogbonge contraception" dan oral combined contraceptive pill while pesin dey take di injections. For some women, to lose plenti weight fit help some women to get back dia natural ovulation and boost dia chance to get belle but e tok say dis kain tin, need planning safely wit specialist doctors "so di pregnancy go dey safe afta washout period of dis drugs". Di British Pregnancy Advisory Service, tok say women for UK, dey face ogbonge challenges wen dem dey try access dia contraceptive method of choice. Lack of appointments, long waiting lists and high costs na just some of di kasala dem dey face, according to di BPAS. Dis na as dem dey ask for beta plan to provide dis choices dem for women.
Sky News
an hour ago
- Sky News
Weight loss jabs - what else don't we know?
👉 Listen to Sky News Daily on your podcast app 👈 The government's health agency, the MHRA, is warning women that they shouldn't use weight loss jabs while pregnant and that the drugs can also affect the reliability of the pill, which has led to a rise in so-called "Ozempic babies". On today's Sky News Daily Niall Paterson talks to Dr Nikita Kanani, a GP and former medical director for primary care at NHS England, about the risks, whether there are other concerns about using them and if there should be tighter restrictions on online sales of the jabs.
